Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE-UK
ISRCTN65432808Phase 3Recruiting
- Sponsor
- Imperial College London
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of budesonide and salbutamol in asthma (2 arms), sponsored by Imperial College London. Primary endpoint: Rate of severe asthma attacks. Started Dec 2024; status: recruiting.
02
Drugs
budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on ISRCTN65432808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65432808.